Influenza vaccination coverage in patients with diabetes mellitus afferent to an Italian hospital

Cocciolo, Giulia; Salvati, Stefano; Allora, Agnese; Molinari, Chiara; Burini, Alice; Scavini, Marina; Odone, Anna

doi:10.1093/eurpub/ckaa165.037

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fear of complications of flu vaccine 47 ( Also, in this study, the vaccination coverage in diabetic patients was 29.7%. In several other studies, 5,10,[17][18][19][20] the vaccination rate in patients with diabetes was between 25% and 70%. Also, in this study, the vaccination coverage in diabetic patients over 60 years was significantly higher than other age ranges.…”

Section: Discussionmentioning

confidence: 84%

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran

Ebrahimzadeh

Bijari

Azarnoosh

et al. 2022

Therapeutic Advances in Vaccines and Immunotherapy

View full text Add to dashboard Cite

Background and Aims: Influenza is an acute respiratory disease with the highest mortality rate in the high-risk groups. Vaccination is a key public health strategy to prevent influenza in high-risk people. This study aimed to assess the influenza vaccination coverage rate and identify its demographic determinants in patients with end-stage renal disease (ESRD), chronic obstructive pulmonary disease (COPD), and diabetes in Birjand, Eastern Iran. Methods: This cross-sectional study included 400 patients (300 diabetic, 60 dialysis, and 40 COPD patients) from September 2017 to August 2018. Using interview method, we completed a questionnaire containing the patients’ demographic characteristics, questions about patients’ knowledge and attitude toward influenza vaccination, the influenza vaccination history, and the most common causes for vaccination. The relationship between the type of disease and patients’ characteristics (exposure) with vaccination coverage (outcome) was investigated. Results: The mean age of participants was 58.7 ± 11.3 years. Also, 58.8% of the patients received at least one dose of the vaccine and the regular injection rate was 32.8%. The coverage of influenza vaccine in dialysis patients was significantly higher than other patients ( p < 0.001). The mean knowledge score was 6.17 ± 2.15 out of maximum 9 scores. There was a positive association between age [ p = 0.001, odds ratio (OR) = 1.04] and patients’ knowledge ( p < 0.001, OR = 1.42) with the vaccination coverage. Conclusion: The coverage of influenza vaccine in high-risk patients in Birjand was low. Hence, it is essential to increase the knowledge of high-risk groups about the importance of influenza vaccination and facilitate their access to vaccines.

show abstract

Section: Discussionmentioning

confidence: 84%

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran

Ebrahimzadeh

Bijari

Azarnoosh

et al. 2022

Therapeutic Advances in Vaccines and Immunotherapy

View full text Add to dashboard Cite

show abstract

Coverage of influenza vaccination of patients with diabetes and determination of barriers for implementation of vaccination

Vlasenko

Давтян

2022

Farm Zh

View full text Add to dashboard Cite

People with diabetes (PWD) are considered to be at high risk of developing severe influenza complications that can lead to hospitalization and sometimes death. It is because of the high risk of developing severe complications that WHO recommends seasonal influenza vaccination (SIV) for PWD. The purpose of the work is to establish the level of coverage of vaccination in PWD and to identify barriers to vaccination in this group in order to overcome obstacles. We analyzed data on the coverage of SIV in PWD and studied the problems of low adherence to vaccination in PWD. We used content analysis, bibliosemantic, analytical, generalizing analyses. An insufficient level of vaccination coverage of PWD has been established. Barriers to vaccination in PWD have been identified. Barriers can be: age, health status, allergic reactions and chronic diseases of people, lower level of education, gender and their employment in economic activities. At the same time, gaps in the knowledge of health care provider, insufficient involvement of endocrinologists and diabetologists in informing PWD about vaccination, a limited number of imported vaccines, and low physical and economic accessibility of vaccines negatively affect the coverage of SIV. A significant factor influencing the level of vaccination coverage of people is their vaccination hesitation. Pharmacists should actively participate in the vaccination campaign by raising public awareness and providing advice to PWD who regularly visit pharmacies. To increase the vaccination coverage of PWD, it is necessary to introduce training programs for doctors and pharmacists to attract them to influenza vaccination companies. Simultaneously conduct educational campaigns and education of PWD. It is advisable to organize a free flu vaccination in medical and diagnostic diabetic hospital (institutions) to increase the physical and economic accessibility of vaccination for PWD. A large number of studies showing the cost-effectiveness of SIV in PWD should be a significant factor for health authorities to improve measures to increase the level of coverage of SIV in patients in this risk group.

show abstract

Influenza vaccination coverage in patients with diabetes mellitus afferent to an Italian hospital

Cited by 2 publications

References 0 publications

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran

Influenza vaccination coverage rates and other related factors in high-risk groups in Birjand, East of Iran

Coverage of influenza vaccination of patients with diabetes and determination of barriers for implementation of vaccination

Contact Info

Product

Resources

About